Treadmill Training and Quality of Life in Parkinson's Disease
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Parkinson's disease (PD) causes motor and non-motor impairments that affect the quality of life of the subjects. The purpose was to assess the effects of treadmill walking training with additional body load on the quality of life and motor symptoms of the subjects with PD.
Methods: Nine subjects with PD, Hoehn and Yahr stages 2 through 3, not demented and with capability to ambulate independently voluntarily participate in this study. The training program was divided into three phases (A1-B-A2): treadmill training with additional body load (A1), control condition (conventional physical therapy group) (B) and treadmill training with load again (A2). Each phase lasted six weeks. The quality of life and motor symptoms were assessed by PDQ-39 and UPDRS, respectively. Both evaluations and training were performed during on-phase of the medication cycle.
| Condition | Intervention |
|---|---|
|
Parkinson's Disease |
Other: Treadmill walking training with additional body load |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Treadmill Walking Training With Additional Body Load Improves Quality of Life in Subjects With Parkinson's Disease |
- The quality of life was measured through Parkinson Disease Questionnaire (PDQ-39). [ Time Frame: 4 times, once before treatment, and 3 after each treatment phase. ] [ Designated as safety issue: No ]
| Enrollment: | 9 |
| Study Start Date: | August 2007 |
| Study Completion Date: | December 2008 |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: PD Group
Nine subjects with idiopathic PD, previously diagnosed by one specialist physician participated in this study.
|
Other: Treadmill walking training with additional body load
The training program was divided into three phases (A1-B-A2):
Each phase lasted six weeks, totaling 18 weeks. Both evaluations and training were performed during on-phase of the medication cycle. |
Eligibility| Ages Eligible for Study: | 51 Years to 81 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Hoehn and Yahr (H-Y) stages 2 through 3
- Absence of dementia (Mini-Mental Status Examination - MMSE, defined according to educational level)
- Capacity to ambulate independently for at least 10 meters
Exclusion Criteria:
- Change medication (dopaminergic) during the study period
- Use treadmill for at least six months prior to the study
- Other neurologic problems or musculoskeletal, cardiovascular and respiratory disease or uncorrected visual deficit that could represent risk and interfere in the accomplishment of the training
Contacts and Locations| Brazil | |
| Universidade Federal de São Carlos | |
| São Carlos, SP, Brazil, 13565-905 | |
| Principal Investigator: | Nadiesca T Filippin, MSc | Universidade Federal de Sao Carlos |
| Study Chair: | Rosana Mattioli, PhD | Universidade Federal de Sao Carlos |
| Study Director: | Paula H Lobo da Costa, PhD | Universidade Federal de Sao Carlos |
More Information
No publications provided
| Responsible Party: | Nadiesca Taisa Filippin, Universidade Federal de São Carlos |
| ClinicalTrials.gov Identifier: | NCT00890669 History of Changes |
| Other Study ID Numbers: | 234/07, CEP/UFSCar |
| Study First Received: | April 28, 2009 |
| Last Updated: | May 1, 2009 |
| Health Authority: | Brazil: Ethics Committee |
Keywords provided by Universidade Federal de Sao Carlos:
|
treadmill training body load quality of life Parkinson's disease Motor Symptoms |
Additional relevant MeSH terms:
|
Parkinson Disease Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Movement Disorders Neurodegenerative Diseases |
ClinicalTrials.gov processed this record on May 16, 2013